A group of independent advisors to the U.S. Food and Drug Administration endorsed the monoclonal antibody nirsevimab, which protects infants from respiratory syncytial virus



View Reddit by DoremusJessupView Source

Leave a Reply

Your email address will not be published. Required fields are marked *